CENTOGENE

CENTOGENE is a German biotechnology and healthcare startup founded in 2006. The company's slogan, "The essential biodata life science partner for rare and neurodegenerative diseases," captures its core mission. CENTOGENE aims to provide data-driven, life-changing answers for patients, physicians, and pharma companies dealing with rare and neurodegenerative diseases. Their unique approach integrates multiomic technologies with the CENTOGENE Biodatabank, enabling dimensional analysis to guide the next generation of precision medicine. The startup's capabilities include rapid and reliable diagnosis for patients, supporting a more precise physician understanding of disease states, and accelerating and de-risking targeted pharma drug discovery, development, and commercialization. Their significant last investment of $45.00M in post-IPO debt came on 01 February 2022 and was made by Oxford Finance. This investment underlines the growing potential and attractiveness of CENTOGENE's innovative approach in addressing critical healthcare challenges.